Validation of the Behavioral Activation for Depression Scale in Individuals With Substance Use Disorders
BADS-SUD
Psychometric Validation of the Behavioral Activation for Depression Scale (BADS) in a Clinical Sample of Individuals With Substance Use Disorders
1 other identifier
observational
289
1 country
1
Brief Summary
This observational study evaluates the psychometric properties of the Behavioral Activation for Depression Scale (BADS) in individuals with substance use disorders. The study examines the scale's internal structure, reliability, and validity using data from 289 participants who completed the BADS. External and incremental validity analyses were conducted in a subsample of 127 participants for whom additional clinical measures were available, including assessments of symptom severity, anxiety, impulsivity, and anger expression. This approach reflects the availability of complete data for each analytic component and allows for a comprehensive evaluation of the BADS in a clinical population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2025
CompletedFirst Submitted
Initial submission to the registry
January 7, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedFebruary 9, 2026
February 1, 2026
1.7 years
January 7, 2026
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychometric Validity of the Behavioral Activation for Depression Scale (BADS)
Psychometric properties of the Behavioral Activation for Depression Scale (BADS), including internal structure (confirmatory factor analysis), internal consistency reliability (Cronbach's alpha / omega), and construct validity (convergent and discriminant validity), assessed using self-report data collected at a single time point in individuals with substance use disorders. Subscale scores will also be examined, with higher scores reflecting greater expression of the respective behavioral domains.
Baseline, pre-intervention (single cross-sectional assessment at study enrollment)
Secondary Outcomes (2)
Convergent and Discriminant Validity of the Behavioral Activation for Depression Scale With the Borderline Symptom List-23
Baseline, pre-intervention (single cross-sectional assessment conducted at study enrollment)
Convergent Validity of the Behavioral Activation for Depression Scale With the Environmental Reward Observation Scale
Baseline, pre-intervention (single cross-sectional assessment at study enrollment)
Study Arms (1)
Individuals With Substance Use Disorders
Single clinical group composed of adults receiving treatment for substance use disorders who completed the Behavioral Activation for Depression Scale (BADS) and additional self-report measures as part of a cross-sectional observational study.
Eligibility Criteria
The study population consists of adults receiving residential treatment for substance use disorders in a therapeutic community setting. Participants represent a clinically relevant population characterized by difficulties in mood regulation, behavioral activation, emotional dysregulation, and related psychological symptoms commonly associated with substance use disorders.
You may qualify if:
- Adults aged 18 years or older.
- Currently receiving treatment or undergoing clinical evaluation for substance use disorders in a therapeutic or clinical setting.
- Ability to read and understand Spanish.
- Ability to provide informed consent.
- Completion of the Behavioral Activation for Depression Scale and at least one additional study questionnaire.
You may not qualify if:
- Severe cognitive impairment or acute psychiatric symptoms that prevent accurate self-reporting.
- Incomplete or missing data on key study measures.
- Current intoxication or acute withdrawal symptoms at the time of assessment that interfere with completing questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Comunidad Terapéutica Under The Tree
Ajijic, Jalisco, 45920, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lauro Gutiérrez Castro
Under The Tree Therapeutic Community
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Invetigator
Study Record Dates
First Submitted
January 7, 2026
First Posted
February 9, 2026
Study Start
March 18, 2024
Primary Completion
November 30, 2025
Study Completion
December 22, 2025
Last Updated
February 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share